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Transmembrane domain Nrg1 mutant mice show altered susceptibility to the
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Abstract
Heavy cannabis abuse increases the risk of developing schizophrenia. Adolescents appear particularly
vulnerable to the development of psychosis-like symptoms after cannabis use. To test whether the
schizophrenia candidate gene neuregulin 1 (NRG1) modulates the effects of cannabinoids in
adolescence, we tested male adolescent heterozygous transmembrane domain Nrg1 mutant (Nrg1 TM
HET) mice and wild type-like littermates (WT) for their neurobehavioural response to repeated
Δ9-tetrahydrocannabinol (THC, 10 mg/kg i.p. for 21 d starting on post-natal day 31). During treatment and
48 h after treatment withdrawal, we assessed several behavioural parameters relevant to schizophrenia.
After behavioural testing we measured autoradiographic CB1, 5-HT2A and NMDA receptor binding. The
hyperlocomotor phenotype typical of Nrg1 mutants emerged after drug withdrawal and was more
pronounced in vehicle than THC-treated Nrg1 TM HET mice. All mice were equally sensitive to THCinduced suppression of locomotion. However, mutant mice appeared protected against inhibiting effects
of repeated THC on investigative social behaviours. Neither THC nor Nrg1 genotype altered prepulse
inhibition. Repeated adolescent THC promoted differential effects on CB1 and 5-HT2A receptor binding in
the substantia nigra and insular cortex respectively, decreasing binding in WT while increasing it in Nrg1
TM HET mice. THC also selectively affected 5-HT2A receptor binding in several other regions in WT mice,
whereas NMDA receptor binding was only affected in mutant mice. Overall, Nrg1 mutation does not
appear to increase the induction of psychotomimetic symptoms by repeated adolescent THC exposure
but may attenuate some of its actions on social behaviour and schizophrenia-relevant neurotransmitter
receptor profiles.

Keywords
adolescence, exposure, thc, repeated, actions, neurobehavioural, susceptibility, altered, transmembrane,
domain, show, nrg1, mutant, mice

Disciplines
Arts and Humanities | Life Sciences | Medicine and Health Sciences | Social and Behavioral Sciences

Publication Details
Long, L. E., Chesworth, R., Huang, X., McGregor, I. S., Arnold, J. C. & Karl, T. (2013). Transmembrane
domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC
exposure in adolescence. International Journal of Neuropsychopharmacology, 16 (1), 163-175.

Authors
Leonora E. Long, Rose Chesworth, Xu-Feng Huang, Iain S. McGregor, Jonathon C. Arnold, and Tim Karl

This journal article is available at Research Online: https://ro.uow.edu.au/hbspapers/2901

International Journal of Neuropsychopharmacology (2013), 16, 163–175. f CINP 2012
doi:10.1017/S1461145711001854

ARTICLE
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Abstract
Heavy cannabis abuse increases the risk of developing schizophrenia. Adolescents appear particularly
vulnerable to the development of psychosis-like symptoms after cannabis use. To test whether the
schizophrenia candidate gene neuregulin 1 (NRG1) modulates the eﬀects of cannabinoids in adolescence,
we tested male adolescent heterozygous transmembrane domain Nrg1 mutant (Nrg1 TM HET) mice and
wild type-like littermates (WT) for their neurobehavioural response to repeated D9-tetrahydrocannabinol
(THC, 10 mg/kg i.p. for 21 d starting on post-natal day 31). During treatment and 48 h after treatment
withdrawal, we assessed several behavioural parameters relevant to schizophrenia. After behavioural
testing we measured autoradiographic CB1, 5-HT2A and NMDA receptor binding. The hyperlocomotor
phenotype typical of Nrg1 mutants emerged after drug withdrawal and was more pronounced in vehicle
than THC-treated Nrg1 TM HET mice. All mice were equally sensitive to THC-induced suppression of
locomotion. However, mutant mice appeared protected against inhibiting eﬀects of repeated THC on
investigative social behaviours. Neither THC nor Nrg1 genotype altered prepulse inhibition. Repeated
adolescent THC promoted diﬀerential eﬀects on CB1 and 5-HT2A receptor binding in the substantia nigra
and insular cortex respectively, decreasing binding in WT while increasing it in Nrg1 TM HET mice. THC
also selectively aﬀected 5-HT2A receptor binding in several other regions in WT mice, whereas NMDA
receptor binding was only aﬀected in mutant mice. Overall, Nrg1 mutation does not appear to increase the
induction of psychotomimetic symptoms by repeated adolescent THC exposure but may attenuate some
of its actions on social behaviour and schizophrenia-relevant neurotransmitter receptor proﬁles.
Received 22 July 2011 ; Reviewed 5 September 2011 ; Revised 7 October 2011 ; Accepted 20 November 2011 ;
First published online 9 January 2012
Key words : Adolescence, cannabinoids, neuregulin 1, schizophrenia, social interaction.

Introduction
The ‘ two-hit ’ hypothesis of schizophrenia suggests
that genetic and environmental risk factors interact to
produce the disorder (Bayer et al. 1999). Onset of
symptoms is usually during adolescence or early
Address for correspondence : T. Karl, PhD or J. C. Arnold, PhD,
Neuroscience Research Australia, Barker St, Randwick, NSW 2031,
Australia.
Tel. : +61 2 9399 1025 Fax : +61 2 9399 1005
Email : t.karl@neura.edu.au or jonathon.arnold@sydney.edu.au

adulthood, periods of major change in brain morphology and neural connectivity and thus increased
vulnerability to insult (Paus et al. 2008). Perturbation to
normal brain maturation during the transition from
adolescence to adulthood, for example, by drug abuse,
might contribute to exacerbation or precipitation of
schizophrenia onset. Cannabis abuse is linked with a
moderate increase in the risk of developing schizophrenia (Moore et al. 2007). Interestingly, individuals
predisposed to schizophrenia are more vulnerable
to adverse eﬀects of cannabis (i.e. hallucinations,
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confusion and learning and memory deﬁcits ; d’Souza
et al. 2005 ; Peters et al. 2009). One mediator of this increased vulnerability appears to be the schizophrenia
candidate gene catechol-O-methyltransferase (Caspi
et al. 2005). Further research has to clarify whether
other candidate genes have similar properties.
Neuregulin 1 (NRG1) is a proposed schizophrenia
susceptibility gene (Stefansson et al. 2002 ; for review
and meta-analysis respectively, see Harrison & Law,
2006 ; Munafo et al. 2006 ; but also see Sanders et al.
2008). One of several transgenic mouse models available for Nrg1 (Duﬀy et al. 2008) contains a heterozygous mutation in the transmembrane domain (Nrg1
TM HET). Nrg1 TM HET mice show face and partial
predictive validity for schizophrenia, exhibiting agedependent locomotor and exploratory hyperactivity
(Karl et al. 2007 ; onset at age 5 months ; reversible
by clozapine treatment ; Stefansson et al. 2002) and
impaired preference for social novelty (O’Tuathaigh
et al. 2007). We have shown that male Nrg1 TM HET
mice possess increased sensitivity to neurobehavioural eﬀects of acute D9-tetrahydrocannabinol [THC ; i.e.
enhancement of prepulse inhibition (PPI), hypolocomotive and anxiogenic eﬀects, selective increases
in c-Fos expression ; Boucher et al. 2007a, b]. This
phenomenon is sex-speciﬁc, since female Nrg1 TM
HET mice do not show increased behavioural sensitivity to acute THC treatment (Long et al. 2010a). The
role of Nrg1 in the response to cannabinoid agonists is
further exempliﬁed by altered rates of tolerance in
adult Nrg1 TM HET mice to the locomotor and anxiogenic eﬀects of the synthetic cannabinoid CP 55 940
(Boucher et al. 2011). Based on our ﬁndings, Nrg1
might be another genetic mediator of increased vulnerability to cannabis-induced psychosis.
Importantly, earlier age of onset of cannabis use
appears to confer increased susceptibility to detrimental eﬀects in adulthood, such as cognitive deﬁcits
(Ehrenreich et al. 1999 ; Pope et al. 2003), and may also
precipitate earlier onset of schizophrenia (Large et al.
2011). Rodent studies also suggest that cognitive deﬁcits are induced by chronic THC exposure during
adolescence, but not adulthood (Quinn et al. 2008 ;
Rubino et al. 2009a, b). Such early cannabinoid exposure may have long-lasting behavioural and neurobiological consequences (Realini et al. 2009) and there
is evidence that both genetic and age-associated factors might play a role in the link between cannabis use
and psychosis. Therefore, we aimed to determine the
eﬀects of acute and chronic adolescent THC on behaviour and receptor binding density in the Nrg1 TM
HET mouse. As these mice exhibit an age-dependent
phenotype, we hypothesized that male adolescent

Nrg1 TM HET mice, like adults (Boucher et al. 2007a),
would be more sensitive to the behavioural eﬀects of
THC in a battery of tests relevant to schizophrenia,
resulting in earlier onset of schizophrenia-relevant
behaviours and a more severe phenotype. We expected that these behavioural changes would be accompanied by alterations in CB1, 5-HT2A and NMDA
receptors (NMDARs). These receptors are relevant
to the pharmacological eﬀects of cannabis and the
pathophysiology of schizophrenia (Dalton et al. 2011 ;
Kang et al. 2009 ; Matsumoto et al. 2005 ; Zavitsanou
et al. 2002, 2004) and levels and/or activation of which
are altered in adult Nrg1 TM HET mice (Bjarnadottir
et al. 2007 ; Dean et al. 2008 ; van den Buuse et al. 2009).
Method
Animals
Male heterozygous Nrg1+/x (Nrg1 TM HET) and wild
type-like control Nrg1+/+ (WT) littermates (Karl et al.
2007) from 14 litters were used. To target adolescence,
the study commenced at post-natal day (PND) 31 (¡2 ;
Spear, 2004). Standard social interaction (SI) opponents were age-matched male A/JArc mice (Animal
Resources Centre, Australia). Mice were pair-housed
with limited environmental enrichment [certiﬁed
polycarbonate mouse igloo (Bioserv, USA) and a
metal ring in the cage lid] under a 12 h light/dark
schedule (lights on 08:30 hours). Food and water were
available ad libitum. Research and animal care procedures were approved by the University of New
South Wales Animal Care and Ethics Committee and
were in accordance with the Australian Code of
Practice for the Care and Use of Animals for Scientiﬁc
Purposes.
Drug treatment
THC (THC Pharm GmbH, Germany) was suspended
in a 1:1:18 mixture of ethanol :Tween 801 :saline and
injected at a volume of 10 ml/kg. Mice received 21
consecutive daily i.p. injections of vehicle or THC
(10 mg/kg ; n=11–16 ; Long et al. 2010b).
Behavioural testing
Mice were behaviourally tested as outlined in Table 1.
Devices were cleaned between trials with 70 %
ethanol.
Body temperature
Mice were assessed for hypothermia (Compton et al.
1993). Body temperature was measured 5 min before

Chronic THC in adolescent Nrg1 mutant mice
Table 1. Test biography of mice
Test
day

Postnatal
day

Test

1
13
14
15
16
17
19
21
23

31
43
44
45
46
47
49
51
53

Body temperature, catalepsy, OF, LD, PPI
OF
NORT habituation trials 1–2
LD, NORT habituation trial 3
NORT habituation trials 4–5
NORT test trials 1–2
Social interaction
PPI
OF, LD, PPI (withdrawal day)

OF, Open ﬁeld ; LD, light–dark test ; PPI, prepulse inhibition ;
NORT, novel object recognition test.
Mice were injected with either vehicle or D9-tetrahydrocannabinol (10 mg/kg body weight) once daily from
test day 1 to day 21 (n=11–16).

and 30 min after injection using a lubricated rectal
thermometer (SDR Clinical Technology, Australia).
Spontaneous locomotor activity
Locomotor activity was measured in an open ﬁeld
(OF) activity chamber (41r41 cm ; Tru-Scan Photo
Beam Activity System ; Coulbourn Instruments, USA)
for 10 min. Horizontal (distance travelled) and vertical
activity (rearing) in central and peripheral zones was
measured by the Tru-Scan system and ANY-mazeTM
video tracking software (Stoelting Co., USA). The ratio
of central : total distance travelled (distance ratio) and
time spent in the centre were taken as measures of
anxiety (Denenberg, 1969).
Light–dark test (LD)
Mice were placed into the opening of a dark box insert
(Coulbourn Instruments) in the OF activity chamber
and allowed to explore freely for 10 min. The ratio of
distance travelled in the light compartment to total
distance travelled (distance ratio) and time spent in
the light compartment were taken as measures of
anxiety.
Novel object recognition test (NORT)
NORT apparatus was a grey Perspex arena
(35r35r30 cm). Mice were habituated to the empty
arena for 5 min twice daily for 2 d. The following day,
mice were habituated to the test procedure (i.e. exposure to objects). The next day, mice were placed in
the arena, which contained two identical objects placed
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in opposite corners, and allowed to explore freely (test
trial 1). In test trial 2, 60 min later, the chamber contained one copy of these objects (familiar object) and
one novel object, in the same positions as in test trial 1.
Object exploration was scored for 5 min by the behaviours nosing (when the mouse directed its nose to an
object at a distance of j1 cm) and rearing on the object.
Social interaction
SI between rodent pairs is used to measure anxietylike behaviours (File & Seth, 2003). Reduction in SI
models aspects of social withdrawal (WD), which also
occurs in schizophrenia (Ellenbroek & Cools, 2000).
Test mice and untreated A/JArc standard opponents
were placed in opposite corners of the NORT arena
and allowed to explore freely for 10 min. Frequency
and duration of the active socio-positive behaviours
general sniﬃng, anogenital sniﬃng, allogrooming,
following and climbing over/under were scored
(Boucher et al. 2007a). Distance travelled was measured by ANY-mazeTM.
Prepulse inhibition
PPI, an operational measure of sensorimotor gating, is
the attenuation of the startle response by a nonstartling stimulus (prepulse) presented before the
startling stimulus (pulse). PPI is impaired in schizophrenia patients (Braﬀ et al. 2001). Startle reactivity
was measured using SR-LAB startle chambers
(San Diego Instruments, USA). Sensitivity of the piezoelectric accelerometer was adjusted for the lower
body weight of the adolescent mice. The PPI test
consisted of 5 min acclimatization to 70 dB background noise, followed by 105 trials presented in a
pseudorandom order : 5r70 dB trials (background) ;
5r80 dB trials ; 5r100 dB trials ; 15r120 dB trials
(startle) and 15 sets of ﬁve trials comprising a prepulse
of 74, 82 or 86 dB presented 32, 64, 128, 256 or 512 ms
(variable inter-stimulus interval) prior to a startling
pulse of 120 dB (PPI response). The inter-trial interval
varied randomly from 10–20 s. Acoustic startle response (ASR) was calculated as the mean amplitude to
all startle trials. Percentage PPI ( %PPI) was calculated
as [(mean startle response (120 dB) – PPI response)/
mean startle response (120 dB)]r100 %. PPI was
averaged across inter-stimulus intervals to produce a
mean %PPI for each prepulse intensity.
Receptor autoradiography
A subset of mice (n=4–5 per factor) were killed after
PPI testing on WD day. Brains were dissected, snap

166

L. E. Long et al.

frozen and stored at x80x C. Coronal sections (14 mm)
were cut and thaw-mounted onto slides.
Autoradiographic binding
Ligand binding and quantiﬁcation was performed as
previously described. For CB1 receptors (CB1Rs) (Deng
et al. 2007), sections were pre-incubated for 30 min in
50 mM Tris-HCl buﬀer (pH 7.4) containing 5 % bovine
serum albumin then incubated for 120 min in the same
buﬀer containing 10 nM [3H]CP-55, 940 (168 Ci/mmol ;
PerkinElmer, USA) in the presence (non-speciﬁc
binding) or absence (total binding) of 10 mM CP 55 940.
After incubation, sections were washed three times in
ice-cold buﬀer (1r60, 1r180 and 1r5 min), dipped
in distilled water and air dried.
For 5-HT2A receptors (5-HT2AR), sections were preincubated in 170 mM Tris-HCl buﬀer (pH 7.4) for 15 min
then incubated for 120 min in the same buﬀer containing 4 nM [3H]ketanserin (88 Ci/mmol; PerkinElmer) in
the presence (non-speciﬁc binding) or absence (total
binding) of 2 mM spiperone (Kang et al. 2009). After incubation, sections were washed in ice-cold buﬀer
(2r10 min), dipped in distilled water and air dried.
For NMDARs, sections were incubated for 2.5 h
in 30 mM Hepes buﬀer (pH 7.5) containing 100 mM
glycine, 100 mM glutamate, 1 mM EDTA and 20nM
[3H]MK-801 (17.1 Ci/mmol ; PerkinElmer) in the
presence (non-speciﬁc binding) or absence (total
binding) of 20 mM MK-801 (Newell et al. 2007). After
incubation, sections were washed in ice-cold 30 mM
Hepes containing 1 mM EDTA (pH 7.5, 3r20 min),
dipped in distilled water and air dried.
Quantiﬁcation
Slides were exposed to Kodak BioMax MR ﬁlm (Kodak,
USA) for 3 months and developed. Films were analysed
with a computer-assisted image analysis system, MultiAnalyst, connected to a GS-690 Imaging Densitometer
(Bio-Rad, USA). Brain regions were identiﬁed with reference to a mouse brain atlas (Paxinos & Franklin, 2004).
Quantiﬁcation of binding in each region was performed
by measuring the average density in each region in two
to three adjacent sections for both hemispheres and
comparing the values against an autoradiographic
standard (GE Healthcare, UK) (Kang et al. 2009).
Statistical analysis
Data were analysed with analysis of variance
(ANOVA ; between-subjects factors : ‘treatment ’
and ‘ genotype’). For OF and PPI, repeated measures
three-way ANOVA was used [within-subjects factor :

‘ interval’ (OF) and ‘ prepulse intensity ’ (PPI)]. Linear
contrasts identiﬁed diﬀerences between levels of prepulse intensity. For all analyses, initial ANOVA was
followed by two- or one-way ANOVAs split by
the corresponding factor(s) if appropriate. Main eﬀects
were regarded as statistically signiﬁcant when p<0.05.
Degrees of freedom, F values and p values (* vs. WT ;
# vs. vehicle of corresponding genotype) are presented. Analysis was performed using SPSS 17.0 IBM,
USA).
Results
At study commencement, WT and Nrg1 TM HET
mice weighed 14.9¡3.0 and 13.7¡3.8 g respectively.
Throughout the study there was no signiﬁcant diﬀerence in body weight between any groups of mice.
Body temperature
THC reduced body temperature in WT and Nrg1 TM
HET mice [thermic response (DxC) : 0.2¡0.3 (vehicle
WT), x1.1¡0.7 (THC WT), 0.5¡0.7 (vehicle Nrg1 TM
HET), x0.8¡0.4 (THC Nrg1 TM HET) ; two-way
ANOVA for ‘treatment ’ : F1,46=5.9, p<0.05].
Locomotor activity
THC decreased locomotion in the OF on day 1 in both
WT and Nrg1 TM HET mice [F1,53=17.8, p<0.001 ;
Supplementary Table 1 ; Fig. 1 a]. This eﬀect was no
longer present on day 13. On WD day, Nrg1 TM HET
mice in both treatment groups showed higher locomotor activity than WT controls (F1,51=6.7, p<0.05).
However, only THC-treated Nrg1 TM HETs displayed
signiﬁcantly lower locomotor activity compared to
vehicle-treated mutants (F1,27=6.6, p<0.05 ; Supplementary Table 1 ; Fig. 1 a).
THC also decreased locomotor activity in the SI test
on day 19 [distance travelled (cm) : 2176.7¡91.6 (vehicle WT), 3078.42¡158.0 (vehicle Nrg1 TM HET),
911.8¡163.6 (THC WT) ; 1328.8¡120.1 (THC Nrg1 TM
HET) ; Supplementary Table 1].
When distance travelled was measured in 5 min
intervals within the OF test, there was an eﬀect of time
on locomotor activity such that distance travelled was
decreased in the second 5 min of the test on all test
days (day 1 : F1,52=109.1, p<0.001 ; day 13 : F1,51=59.4,
p<0.001 ; WD day : F1,51=17.5, p<0.001 ; Fig. 1 c). THCtreated mutant mice of both genotypes showed greater
habituation than vehicle-treated mice after acute and
chronic administration (intervalrtreatment interaction, day 1 : F1,52=9.3, p<0.01 ; day 13 F1,51=26.7,
p<0.001).
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(a)
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*
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3000
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THC WT
Veh HET
THC HET
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*
50

1000
###
0
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0
1
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1

Day
(c)

13
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Day

Distance travelled (OF) - habituation

Distance (cm)

2000
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1500

Vehicle HET
THC WT
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THC HET

500
0
5

10 5
1

10 5
13

10

min

WD

Day
Fig. 1. Horizontal locomotor and vertical exploratory activity after injection of D9-tetrahydrocannabinol (THC ; 10 mg/kg).
(a) Overall distance travelled ; (b) rearing ; (c) 5-min interval habituation of distance travelled in the open ﬁeld (OF) on days 1, 13
and withdrawal (WD) day. Data represent means¡S.E.M. ; n=12–16. WT, Wild-type litter ; HET, heterozygous ; Veh, vehicle.
* p<0.05, ** p<0.01 vs. WT receiving corresponding treatment ; # p<0.05, ## p<0.01, ### p<0.001 vs. vehicle (analysis of variance).

Exploratory activity
THC reduced rearing in the OF in both genotypes on
days 1 and 13 but not on WD day (e.g. day 1 : F1,53=49.4,
p<0.001 ; Supplementary Table 1 ; Fig. 1 b). Exploratory
activity was higher in vehicle-treated Nrg1 TM HET
mice than in their WT counterparts in the OF on day 13
(F1,26=5.1, p<0.05 ; Supplementary Table 1 ; Fig. 1 b).
Anxiety
Acute administration of THC on day 1 induced taskspeciﬁc anxiogenic-like behaviour in the OF in WT
mice only, which showed more pronounced reductions in the time spent in the centre (F1,24=11.2,
p<0.01) and the distance ratio (F1,24=9.4, p<0.01)
compared to Nrg1 TM HET mice (Supplementary
Table 1 ; Fig. 2 a, c). Chronic THC administration induced anxiogenic-like behaviour in the OF in both
genotypes, as shown by the reduced OF distance ratio

in WT and Nrg1 TM HET mice on day 13 (F1,51=20.2,
p<0.001 ; Supplementary Table 1). In contrast, in the
LD, there were no eﬀects of ‘ treatment ’ or ‘genotype’
on anxiety-related parameters (Fig. 2 b, d).
Learning and memory
Unexpectedly, exploration times were generally low in
the NORT (<15 s/5-min trial) and object recognition
bias was not highly prevalent in control mice, although the same NORT protocol previously yielded
high recognition scores in our laboratory. Thus, NORT
data are not shown.
Social interaction
There were no eﬀects of THC treatment or genotype on
total time spent in SI (data not shown). However, when
examining individually scored behaviours, THC
reduced the frequency and duration of general sniﬃng,
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Time spent in light compartment (LD)
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300
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Time (s)

Time (s)
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0
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##
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(d)
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0

0
1

13
Day
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1

13
Day
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Fig. 2. Anxiety-related measures after injection of D9-tetrahydrocannabinol (THC) (10 mg/kg). (a) Time spent in the central
area of the open ﬁeld (OF) on days 1, 13 and withdrawal (WD) day ; (b) time spent in the light compartment of the light–dark (LD)
on days 1, 15 and WD ; (c), distance ratio (OF) ; (d) distance ratio (LD). Data represent means¡S.E.M. ; n=11–16. WT, wild-type
litter ; HET, heterozygous ; Veh, vehicle. ## p<0.01 vs. vehicle (analysis of variance).

the frequency of anogenital sniﬃng (e.g. anogenital
sniﬃng : F1,50=14.3, p<0.001 ; Supplementary Table 1 ;
Fig. 3 a, b) and the duration of allogrooming (data not
shown). The eﬀect of THC on the duration of general
sniﬃng and frequency of anogenital sniﬃng was speciﬁc to WT mice and while the frequency of general
sniﬃng was reduced by THC in both WT and Nrg1 TM
HET mice, it was signiﬁcantly higher in THC-treated
Nrg1 TM HET mice (F1,24=5.7, p<0.05) compared to
THC-treated WT mice (Supplementary Table 1).
ASR and PPI
ASR
Chronic THC decreased the ASR in both WT and Nrg1
TM HET mice (F1,51=19.5, p<0.001 ; Supplementary
Table 2 ; Table 2).
Prepulse inhibition
PPI increased with increasing prepulse intensity on
each test day (Supplementary Table 2 ; Fig. 4 a–c).

Acute THC decreased PPI at the 74 dB prepulse
intensity in Nrg1 TM HET mice only (Nrg1 TM HET
74 dB : F1,27=4.8, p<0.05 ; Supplementary Table 2 ;
Fig. 4 a).
CB1, 5-HT2A and NMDAR receptor binding
Figure 5 depicts representative autoradiograms
for [3H]CP 55 940, [3H]ketanserin and [3H]MK-801
binding in WT and Nrg1 TM HET mice. THC
reduced [3H]CP-55 940 CB1R binding in the hippocampus (HPC) and ventromedial hypothalamus of
WT and Nrg1 TM HET mice. In the substantia nigra,
CB1R binding was reduced in vehicle-treated Nrg1 TM
HET mice compared to vehicle-treated WT littermates,
while THC reduced CB1R binding in WT mice but increased it in Nrg1 TM HET mice [treatmentrgenotype
interaction : F1,13=28.2, p<0.001 ; Supplementary
Table 3 ; Fig. 6 a]. There was a trend towards a reduction in CB1R binding by THC in the external globus
pallidus in both genotypes (p=0.06).
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(b)

General sniffing

Anogenital sniffing episodes (n)

General sniffing episodes (n)

(a)
80
60

*
###
40
###
20
0

169

Anogenital sniffing
25
20
15
10

##

Veh WT
THC WT
Veh HET
THC HET

5
0

Fig. 3. Measures of social interaction after injection of D9-tetrahydrocannabinol (THC) (10 mg/kg) on day 19. (a) Frequency of
general sniﬃng ; (b) anogenital sniﬃng. Data represent means¡S.E.M. ; n=12–14. WT, wild-type litter ; HET, heterozygous ; Veh,
vehicle. * p<0.05 vs. WT ; ## p<0.01, ### p<0.001 vs. vehicle (analysis of variance).

Table 2. Acoustic startle response

Discussion
Nrg1 TM HET

WT
Day

Vehicle

THC 10

Vehicle

THC 10

1
21
WD

51.7¡5.8
73.2¡5.7
69.0¡6.2

45.6¡5.0
46.8¡4.3##
87.2¡11.9

45.3¡3.5
57.0¡6.5
52.7¡6.0

34.0¡3.8
39.5¡2.4#
60.5¡7.0

Nrg1 TM HET, heterozygous transmembrane domain Nrg1
mutant ; WT, wild-type-like littermate control ;
WD, withdrawal day.
Chronic D9-tetrahydrocannabinol (THC ; 10 mg/kg) reduces
the startle response (arbitrary units) to a 120 dB acoustic
stimulus.
Data represent means (¡S.E.M.) ; n=12–15.
#
p<0.05 ; ## p<0.01 (vs. vehicle).

[3H]Ketanserin 5-HT2AR binding was also genotype
and treatment dependent. Speciﬁcally, vehicle-treated
Nrg1 TM HET mice showed reduced 5-HT2AR binding
in the agranular insular and cingulate cortices but
increased binding in the caudate putamen compared
to WT controls. THC reduced 5-HT2A binding in the
anterior insula, cingulate cortex and ventral pallidum
and increased binding in the caudate putamen of
WT mice, but in Nrg1 TM HET mice THC increased
5-HT2AR binding only in the anterior insula (F1,6=39.8,
p<0.001 ; Supplementary Table 3 ; Fig. 6 b).
The eﬀects of THC on [3H]MK-801 NMDAR binding were restricted to mutant mice, such that THC
increased binding in the auditory cortex, cingulate
cortex and hippocampus of Nrg1 TM HET, but not WT
mice (e.g. Nrg1 TM HET in HPC : F1,7=15.0, p<0.01 ;
Supplementary Table 3 ; Fig. 6 c).

This study describes novel eﬀects of adolescent THC
on behaviour and receptor binding in a mouse model
for the schizophrenia candidate gene NRG1. THC
produced acute and chronic hypolocomotor and
hypoexploratory responses in both Nrg1 TM HET and
WT mice, but only mutant mice showed residual hypolocomotion after THC WD. In contrast, mutant mice
were less susceptible to other eﬀects of THC, such as
acute anxiogenic eﬀects and reduction in investigative
sniﬃng during SI elicited by repeated THC exposure.
Repeated adolescent THC notably promoted diﬀerential eﬀects on CB1R and 5-HT2AR density in the substantia nigra and insular cortex respectively, such
that THC decreased binding density in WT but increased it in Nrg1 TM HET mice. While repeated
adolescent THC also aﬀected 5-HT2AR density in WT
mice in the ventral pallidum, caudate putamen and
cingulate cortex, no such eﬀects were observed in
Nrg1 TM HET mice. Interestingly, the opposite proﬁle was evident for NMDAR binding : repeated
adolescent THC increased binding density in the
hippocampus and auditory and cingulate cortices in
mutants only.

Behavioural eﬀects of Nrg1 genotype and THC
treatment
Baseline hyperactivity in Nrg1 TM HET mice
emerged at an earlier age (PND 49–53) in this study
than previously reported (Karl et al. 2007). As the Nrg1
TM HET phenotype is sensitive to environmental
modiﬁcation (Karl et al. 2007), eﬀects of the individually ventilated cage housing used in the present study
and conventional housing used previously as well as
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Fig. 4. Sensorimotor gating after injection of D9tetrahydrocannabinol (10 mg/kg). (a–c) % Prepulse
inhibition (PPI) on days 1, 21 and withdrawal day.
Data represent means¡S.E.M. ; n=12–15. WT, wild-type litter ;
HET, heterozygous ; Veh, vehicle. # p<0.05 vs. vehicle
(analysis of variance).

the adolescent treatment procedure (i.e. stress of daily
i.p. injections) might have contributed to the earlier
phenotype onset (Kallnik et al. 2007). Repeated OF
testing is unlikely to have contributed to the earlier
onset as we have previously shown that locomotor
activity is not altered by repeated exposure of Nrg1
mutant mice to the OF paradigm (Boucher et al. 2011 ;
Karl et al. 2007).

Acute THC elicited the typical cannabinoid eﬀects
of hypothermia and hypolocomotion in WT mice,
similarly to our previous studies (Boucher et al. 2007a ;
Long et al. 2010b). These eﬀects, observed at around
PND 31, may represent one of the earliest manifestations of activation of CB1Rs, which are suggested to
be functionally immature until around PND 23, i.e.
after weaning (Fride & Mechoulam, 1996). THC induced hypolocomotion in adolescents of both genotypes, which contrasts with the heightened susceptibility to THC-induced hypolocomotion of adult
Nrg1 TM HET mice (Boucher et al. 2007a). It is possible
that using a lower, less sedative dose of THC in the
present study, such as 1 mg/kg, may have unmasked
some subtle diﬀerences in locomotor eﬀects of THC
between genotypes at this younger age.
Adolescent mice developed an overall tolerance to
THC-induced hypolocomotion in the OF after chronic
exposure. While tolerance to cannabinoid agonistinduced hypolocomotion is common (Boucher et al.
2011 ; Howlett et al. 2004), adolescent rats have
been reported to be less susceptible than adults to
the development of tolerance (Wiley et al. 2007).
Interestingly, in THC-treated mice of both genotypes,
hypolocomotor tolerance was evident only in the
ﬁrst half of the 10 min OF test on day 13, suggesting
that the rate of tolerance to some THC eﬀects may
interact with its eﬀects on habituation to the test
environment. On the other hand, residual hypolocomotion was present in THC-treated Nrg1 TM
HET, but not WT mice in the OF and LD at WD.
One possible interpretation for this phenomenon is
that THC induced selective neurobiological alterations
in Nrg1 TM HET mice, which diminished the emergence of the typical hyperactive phenotype of these
mice.
There were no baseline genotype diﬀerences in
generalized anxiety-like behaviour in the adolescent
mice, conﬁrming the age-dependency of phenotypic
features of this Nrg1 mutant mouse model, since a
task-speciﬁc, anxiety-related phenotype has been
observed in adult Nrg1 TM HET mice (Karl et al.
2007). Acute THC induced anxiety-like eﬀects taskspeciﬁcally in the OF, predominantly in WT mice,
whereas chronic eﬀects were detectable in all mice.
The data suggest that adolescent WT and Nrg1 TM
HET mice have similar responses to chronic, but
not acute, eﬀects of THC on anxiety measures and that
the eﬀects of repeated adolescent THC exposure are
not long lasting. This also appears to be an agedependent phenomenon, as adult Nrg1 mutants exhibited an increased sensitivity to acute THC (Boucher
et al. 2007a).

Chronic THC in adolescent Nrg1 mutant mice
[3H]CP 55,940

[3H]ketanserin

171

[3H]MK-801

PrL
AI

Cg
CPu
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GPe

Au

HPC

VMH

SN
Fig. 5. Representative autoradiograms showing [3H]CP 55 940, [3H]ketanserin and [3H]MK-801 binding in speciﬁc brain regions
in wild-type litter and heterozygous transmembrane domain Nrg1 mutant (Nrg1 TM HET) mice. PrL, Prelimbic cortex ; AI,
agranular insular cortex ; Cg, cingulate cortex ; CPu, caudate putamen ; VP, ventral pallidum ; GPe, external globus pallidus ; Au,
auditory cortex ; HPC, hippocampus ; VMH, ventromedial hypothalamus ; SN, substantia nigra.

Interestingly, adolescent Nrg1 TM HET mice were
resistant to THC-induced suppression of investigative
social behaviours. There were no baseline diﬀerences
between vehicle-treated mutant and WT mice in the SI
test, which intends to model both social anxiety and
social WD. While acute THC reduced total SI to a
similar extent in adult Nrg1 TM HET and WT mice
(Boucher et al. 2007a), we now show that THC selectively reduced general sniﬃng and anogenital sniﬃng
in adolescent WT mice. This selective reduction in investigative social behaviour cannot be explained by a
locomotor suppressant eﬀect of THC, since THC reduced locomotion to the same extent in both WT and
Nrg1 TM HET mice. It is possible that adolescent Nrg1
TM HET mice undergo diﬀerential neurobehavioural
adaptations to repeated THC that render them less
susceptible to reductions in social behaviour induced
by the drug – an eﬀect worthy of consideration in light

of the purported relief from negative symptoms
experienced by cannabis users with schizophrenia
(Smit et al. 2004).
There were no baseline genotype diﬀerences in
startle response and PPI. Importantly, the PPI deﬁcit of
Nrg1 TM HET mice initially reported (Stefansson et al.
2002) has not been replicated reliably (Boucher et al.
2007a ; van den Buuse et al. 2009 ; but also see
Boucher et al. 2011 ; Karl et al. 2011). Acute THC treatment selectively reduced PPI at the lowest prepulse
intensity in Nrg1 TM HET mice but did not alter the
startle response, while chronic THC reduced the startle response in both genotypes but did not alter PPI
during treatment or WD. These data suggest that THC
has diﬀerential acute eﬀects on sensorimotor gating in
adult and adolescent Nrg1 TM HET mice, since we
have previously found that a single THC exposure
enhanced PPI in adult Nrg1 TM HET mice, while no
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Fig. 6. Autoradiographic binding of (a) [3H]CP-55 940, (b)
[3H]ketanserin and (c) [3H]MK-801 on withdrawal day. Data
represent mean binding density nCi/mg tissue (¡S.E.M.) ;
n=4–5. WT, wild-type-like littermate control ;
HET, heterozygous ; Veh, vehicle ; CPu, caudate putamen ;
HPC, hippocampus ; VMH, ventromedial hypothalamus ; SN,
substantia nigra ; GPe, external globus pallidus ; AI, agranular
insular cortex ; VP, ventral pallidum ; PrL, prelimbic cortex ;
Cg, cingulate cortex ; ACo, auditory cortex ; PMCo,
posteromedial cortical amygdaloid nucleus. * p<0.05,
** p<0.01 vs. WT ; # p<0.05, ## p<0.01, ### p<0.001 vs. vehicle
(analysis of variance).

eﬀect was observed in WT mice (Boucher et al. 2007a).
Furthermore, repeated THC exposure had no eﬀect on
PPI in adolescent WT and Nrg1 TM HET mice, similarly to our recent ﬁndings in adult mutants after repeated exposure to a synthetic cannabinoid agonist
(Boucher et al. 2011).

We report for the ﬁrst time a decrease in CB1R density
in the substantia nigra of adolescent Nrg1 TM HET
mice. Since the binding ligand we used is a CB1R
agonist, it is possible that this ﬁnding reﬂects altered
binding site aﬃnity rather than overall receptor number. Nevertheless, we note with interest that using the
same radioligand ([3H]CP 55 940), CB1R binding was
modestly increased in the substantia nigra in adult
Nrg1 TM HET mice (Newell et al. unpublished observations), suggesting that the developmental trajectory of CB1R expression between adolescent and adult
mice diﬀers between Nrg1 TM HET and WT mice.
Within the basal ganglia, CB1R mRNA is synthesized
in striatal medium spiny neurons and the receptor
protein is transported to terminals projecting to the
substantia nigra via the direct pathway and the external globus pallidus via the indirect pathway (Julian
et al. 2003 ; van der Stelt & di Marzo, 2003). These
pathways facilitate and inhibit movement, respectively. The reduced CB1R binding in vehicle-treated
adolescent mutant mice appears speciﬁc to the direct
pathway, since CB1R binding was not altered in the
external globus pallidus. Combined with the observation that mRNA encoding ErbB4 receptors for
NRG1 is localized on dopaminergic neurons in the
substantia nigra (Abe et al. 2009), it is possible to
speculate that hyperactivity in Nrg1 mutant mice involves altered nigral dopaminergic neurotransmission, possibly related to reduced CB1R availability in
the direct pathway. We also report for the ﬁrst time
genotype diﬀerences in the eﬀects of repeated adolescent THC on CB1R binding in the substantia nigra,
such that it reduced CB1R binding in WT mice (consistent with prior research ; Romero et al. 1997) but increased binding in Nrg1 TM HETs. Combined with a
trend towards reduced CB1R binding in the external
globus pallidus of both WT and mutant mice treated
with THC, this suggests an involvement of both direct
and indirect pathway CB1Rs in the locomotor eﬀects of
chronic THC in WT mice. The increased CB1R binding
in the substantia nigra of THC-treated Nrg1 TM HET
mice may represent a maladaptive or compensatory
response underlying the persistent reduction in locomotor activity after THC WD in mutant mice.
5-HT2AR binding was reduced in the anterior insular and cingulate cortices and increased in the caudate
putamen of drug-free, adolescent Nrg1 TM HET mice.
This is consistent with reduced 5-HT2AR density in
prefrontal and other cortical regions in schizophrenia
(Kang et al. 2009 ; Matsumoto et al. 2005 ; Pralong et al.

Chronic THC in adolescent Nrg1 mutant mice
2000). Given that our data are from mice in mid-adolescence, the ﬁndings are particularly relevant to observations in the early stages of schizophrenia in
humans, such as reduction in cortical 5-HT2ARs in individuals at high risk for schizophrenia (Hurlemann et
al. 2008) and in ﬁrst-episode patients (Rasmussen et al.
2010), and increased subcortical 5-HT2ARs (Erritzoe et
al. 2008) in ﬁrst-episode patients. While this suggests
that changes in 5-HT2ARs may be an early manifestation of schizophrenia neuropathophysiology, it is
possible that genetic inﬂuences such as Nrg1 mutation
may alter the development of the expression of this
receptor, since we have previously observed a global
increase in 5-HT2ARs in adult Nrg1 TM HET mice
(Dean et al. 2008). The eﬀects of THC on 5-HT2ARs,
similar to CB1Rs, also appear to be genotype-speciﬁc,
such that THC reduced binding in the agranular
insula and ventral pallidum in WT mice but increased
or did not change it in mutants. Overall, our results
suggest that Nrg1 modulates 5-HT2AR binding density in brain regions relevant to schizophrenia and
social anxiety (Furmark, 2009 ; Vertes, 2006 ; Wylie &
Tregellas, 2010), which may subserve the diﬀerential
patterns in THC eﬀects on social anxiety in the present
study.
We observed no baseline genotype diﬀerences in
NMDAR binding. This is in line with a previous report
of hypophosphorylation, but no change in total protein levels, of the NMDAR NR2B subunit in adult Nrg1
TM HET mice (Bjarnadottir et al. 2007). Meanwhile,
NMDAR binding density was selectively increased
in the hippocampus and auditory and cingulate cortices of THC-treated mutant mice. This may represent
an adaptation to THC-induced changes in endocannabinoid control of synaptic transmission (Bodor
et al. 2005 ; Brown et al. 2003 ; Hoﬀman et al. 2010). Since
NMDAR antagonists generally induce hyperactivity,
increased NMDAR density may also underlie the
persistent hypolocomotion after THC WD in mutant
mice.
Here, we add to the Nrg1 mutant mouse model
literature by reporting adolescence-speciﬁc and
genotype-dependent diﬀerences in the neurobehavioural response of these mice to THC. We hypothesized that adolescent Nrg1 TM HET mice would be
more susceptible to the hypolocomotor, hyposocial
and anxiogenic eﬀects of THC. However, we found no
diﬀerence in the sensitivity of mutant mice to locomotor reduction by THC and, in fact, mutants were
less susceptible to THC-induced reduction in social
behaviour and to induction of anxiety-like behaviour
by acute THC. Furthermore, the changes in CB1, 5HT2A and NMDAR receptors in adolescent mutants
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that we observe are diﬀerent to those previously found
in adult mice, supporting the implications of our behavioural data that there are developmental diﬀerences in both the baseline phenotype of these mice and
in their behavioural and neurochemical response to
chronic cannabinoid agonist exposure. Overall, these
ﬁndings are consistent with evidence for diﬀerential
eﬀects of THC between adolescents and adults and
between ‘vulnerable ’ (i.e. genetically modiﬁed) and
‘healthy ’ brains.
Note
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
pnp).
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